SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-037753
Filing Date
2020-06-18
Accepted
2020-06-18 21:32:57
Documents
2
Period of Report
2020-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5615
2 POA DOCUMENT poa.txt EX-24.3_923419 3622
  Complete submission text file 0001209191-20-037753.txt   10633
Mailing Address C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451
Business Address
Morrison Briggs (Reporting) CIK: 0001654430 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39335 | Film No.: 20974090

Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Issuer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations